| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8272714 | Journal of the Neurological Sciences | 2018 | 7 Pages |
Abstract
Across heterogeneous study designs and patient populations found in real-world studies, the consensus 1-year fingolimod persistence rate exceeded 80%, consistent with persistence rates identified in the recently-completed trial, PREFERMS.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Ageing
Authors
Daniel Kantor, Kristen Johnson, Maria Cecilia Vieira, James Signorovitch, Nanxin Li, Wei Gao, Valerie Koo, Emilie Duchesneau, Vivian Herrera,